Cyclooxygenase inhibition in patients with coronary artery disease

J Am Coll Cardiol. 2004 Feb 18;43(4):532-3. doi: 10.1016/j.jacc.2003.11.018.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Aspirin / therapeutic use
  • Coronary Artery Disease / enzymology*
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors / therapeutic use*
  • Dinoprost / analogs & derivatives*
  • Dinoprost / pharmacology
  • Humans
  • Isoenzymes / antagonists & inhibitors
  • Membrane Proteins
  • Platelet Aggregation Inhibitors / therapeutic use
  • Prostaglandin-Endoperoxide Synthases
  • Sulfonamides / therapeutic use
  • Thromboxane A2 / antagonists & inhibitors

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Isoenzymes
  • Membrane Proteins
  • Platelet Aggregation Inhibitors
  • Sulfonamides
  • 8-epi-prostaglandin F2alpha
  • Thromboxane A2
  • Dinoprost
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • PTGS1 protein, human
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases
  • Aspirin
  • nimesulide